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Swiss mice injected subcutaneously with suspensions of spleen cells

or an

extract of spleens from mice infected with Friend virus develop resistance to

subsequent intravenous inoculation of Friend virus. A single injection of either
Friend virus or Friend cells induces resistance. Immunized mice display
resistance when challenged 6 months after immunization and survive for at least
20 weeks after infection. Neutralization tests indicate that serum, but not
lymphoid cells of resistant animals, can neutralize Friend virus. In vitro
neutralization tests indicate that residence of virus within the peritoneal cavity
of immune mice for 1 h sharply reduces the infective titer of the virus.
Resistance to infection with Rauscher virus or
Friend virus has been induced in mice by
immunization with Formalin-killed virus (6, 7)
but not by administration of a strain of Friend
virus which gives rise to regressive disease (15).
Resistance to Friend disease may, however, be
produced by infection with Rawson-Parr virus
(4, 17), the lymphatic leukemia virus (5) isolated by Steeves et al. (19) and by murine
sarcoma virus of Moloney (16). Nonspecific
resistance to infection with Friend virus may be
produced by immunization with an attenuated
strain of Mycobacterium bovis (9).
Intravenous or intraperitoneal injection of
Friend virus produces florid infection in mice
(11), but lesser degrees of infection follow subcutaneous introduction of virus. Old et al. (12)
found that the mortality rates were considerably reduced among mice injected subcutaneously with either large numbers of spleen cells
from mice with Friend disease (Friend cells) or a
high concentration of virus in comparison to
those after intravenous injection of similar
amounts of infectious material. The surviving
animals developed antibodies cytotoxic for
Friend cells.
Studies of resistance produced in mice by
subcutaneous injection of either Friend virus or
Friend cells are presented in this investigation.
Mice so immunized are resistant to challenge
with virus administered intravenously and develop antibodies capable of neutralizing Friend
virus.

MATERIALS AND METHODS
Mice. Outbred Swiss mice were obtained from the
colony maintained at the Rocky Mountain Laboratory
(RML), Hamilton, Mont.
Virus. Friend virus (FV) was obtained from R. W.
Sidwell and has been passed continuously in RML
mice for a period of years. Pools of virus were prepared
from the spleens of mice infected 4 weeks previously
by intravenous (i.v.) injection of FV. A suspension of
10 or 20% spleen tissues was prepared and centrifuged
(7). The clarified supernatant fluid was distributed in
1.0-ml amounts in ampoules which were sealed and
frozen at -70 C. The mean lethal dose (LD50) of the
virus pools used in these experiments varied from
10-7to 10'.
Immunization. Mice were immunized by subcutaneous (s.c.) injection of either Friend spleen cells (FC)
or FV. Suspensions of spleen cells prepared by teasing
the spleen or sieving the organ through a stainless
steel screen obviously yield both infected cells and
virus. For purposes of discussion the term FV is used
to describe the supematant fluid obtained after centrifugation at 4,300 x g for 30 min of a suspension of
spleen cells from infected mice, and FC to describe
the suspension itself. Initially, mice were immunized
by the method described by Old et al. (12) utilizing 3
s.c. injections of FC suspended in balanced salt
solution and administered at intervals of 3 weeks.
About 107, 5 x 107, and 10 x 107 cells were used for the
first, second, and third injections, respectively.
Subsequently, a single s.c. injection of either FC or FV
was found to induce resistance.
Challenge tests. Groups of mice immunized by
these methods, as well as normal mice of the same
age, were challenged i.v. with FV. In some experiments only a single dilution of virus contained in 0.2
708
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ml of inoculum was employed, but in others various neal fluids from immune and normal mice were
dilutions of virus were administered to groups of pooled separately. The cells were separated from the
immune and normal animals. Initially, tests were fluid by centrifugation at 200 x g for 15 min and
terminated 11 days after infection of the animals. At washed twice. The cells and fluid from each group of
this time splenomegaly was not marked, but the mice were injected i.v. in 0.2-ml amounts into groups
presence and number of foci in the spleen (2, 13) of
of 10 animals each. The fluids were used whole and in
each animal was used as a criterion of the presence of dilutions of 10' and 10-2 and the cell suspensions
Friend disease (FD). However, in most of the studies were adjusted to contain either 1.6 x 101 to 1.9 x 101
the animals were autopsied 28 days after infection, (from immune mice) or 1.6 x 101 to 1.9 x 101 (from
and in these experiments the degree of splenomegaly normal mice) cells per ml. The animals were autopas well as the occurrence of splenic foci were detersied 20 days later and the spleen weights and number
mined. Splenomegaly was considered to be present if of foci per spleen were determined. To control the
the weight of the test spleen was at least two times experiment, a sample of FV was kept at 37 C for 1 h.
greater than the average weight of the spleens of the Dilutions of 10-1, 10-2, and 10-I were prepared, and
control animals. In some experiments survival for 20 0.2-ml amounts were injected i.v. into groups of 10
weeks after challenge was used as a determinant of mice each.
resistance.
In vitro neutralization. Tests were done with sera
RESULTS
from individual normal and immune mice. The sera
Immunization with multiple injections of
were diluted 1:4, mixed with equal quantities of a
10-2s3 dilution of FV, incubated for 30 min at 37 C, suspensions of FD spleen cells. Mice immuand 0.4 ml of the mixture was injected i.v. into groups nized by 3 s.c. injections of FC were divided into
of five mice each. The recipient animals were held for 3 groups and challenged by i.v. injection of
21 days before they were autopsied and spleen weights various dilutions of FV 49 days after the last
and foci were recorded. Spleen and lymph node cells dose of FC (89 days after the primary immunizfrom the animals from which sera were obtained were
as controls in the experitested for their ability to neutralize virus. The spleen, ing dose). Included
groups of normal mice of
1)
were
ment
(Table
the inguinal, axillary, and mesenteric lymph nodes
from individual mice were pooled and sieved through the same age infected with the same dilutions of
a 60-mesh stainless steel screen. The cells were FV and groups of uninfected normal and immususpended in Eagle minimal essential medium nized mice. All animals were sacrificed 28 days
(MEM) and washed two times by centrifugation. The after infection, the spleen and body weights
number of cells was determined and equal amounts of were determined, and the number of splenic foci
cell suspension and a 10-23 dilution of FV were was counted. The spleen weights of uninfected
mixed. After incubation for 30 min at 37 C, 0.4 ml of normal and immune mice were almost identical
the cell-virus suspension was injected i.v. into each of and these spleens appeared to be normal in
five mice. The recipients were examined 21 days later.
In vivo neutralization. Five normal and five other aspects. There was marked splenomegaly
immune mice were each injected i.p. with 1.5 ml of a among all groups of unimmunized mice infected
10-1 dilution of FV. One hour later the animals were with FV, whereas only minimal splenomegaly
killed and the peritoneal fluid was harvested. Perito- was observed in 1 of the 36 immunized mice
TABLE 1. Resistance of mice immunized by 3 subcutaneous injections of Friend spleen cell suspensions to
infection with FV administered i.v. 49 days after last immunizing injection

miceNoo

Gop|mice |

1
2
3
4
5
6
7
8
a

10
10
8
8
9
10
9
9

IDilution of
used for
status
| FV
challenge

statuse

Normal
Normal
Normal
Immune
Immune
Immune
Normal
Immune

10-,

10-2
10-3

10-l
10-'
10-3
0
0

No. of splenic foci

Spleen wt
Avg (g)

Range (g)

2.65
1.78
1.25
0.22
0.19
0.26
0.20
0.23

0.29-4.55

1.13-2.80
0.43-2.66
0.16-0.28
0.13-0.30
0.14-0.57

0.14-0.30'
0.15-0.34

Degree of
splenomegalya

13.25 x
8.9xc
6.2 xd
0.96x
0.83x
1.13 x

0

1-10

10-50 Confluent

9

1

10
8
6
2
4
9
9

2
7
5

Average spleen weight of infected mice per average spleen weight of uninfected mice.

b 1 versus 4: p

<0.001.

2 versus 5: p < 0.001.
d 3 versus 6: p < 0.005.
e
Three s.c. injections of FC at 3-week intervals; 107, 5 x 107, and 10 x 107 FC at the first, second, and third

c

injections, respectively.
f 7 versus 8: p < 0.30.
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challenged with FV. A total of 27 of 28 infected,
unimmunized mice had confluent foci in the
spleen.
Immunization with a single injection of
FC. Mice were injected s.c. with 1.2 x 106 FC.
After an interval of 67 days, groups of immunized and normal mice of the same age were
infected by i.v. injection of varying doses of FV.
A group of normal and a group of immunized
mice were retained as unchallenged controls.
All mice were sacrificed 4 weeks after infection,
the spleen and body weights were determined,
and the number of splenic foci was recorded.
The results are shown in Table 2. Splenomegaly
was present in the normal mice challenged with
FV (groups 1, 2, 3). Among the 28 mice in these
groups, spleens of 24 animals weighed two times
more than the average spleen of uninfected,
unimmunized animals (group 7). Foci were
confluent on the spleens of 27 of 28 mice in these
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three groups. Only one mouse in the immunized, challenged group had splenomegaly; 18
of 24 had no splenic foci, and only one had
confluent foci. One of the uninfected, immunized mice in group 8 had an enlarged spleen
with confluent foci, indicating that the immunizing material had produced FD which was
manifest 95 days after the s.c. injection of FC.
Immunization with a single injection of
FV. Mice were immunized by s.c. injection with
0.1 ml of a 1:10 dilution of FV. After an interval
of 114 days, three groups of eight immune
animals and three groups of eight normal animals of the same age were segregated. One
group of immune mice and one group of normal
mice were not infected with FV, but separate
groups of normal and immune mice were infected i.v. with 0.2 ml of either a 10-2 or 10-3
dilution of FV. All mice were sacrificed 28 days
later. The results are shown in Table 3. It was

TABLE 2. Immunization of mice with a single s.c. injection of FC followed 67 days later by challenge
with virus i.v. and autopsy 28 days after challenge
Spleen wt
Group
No: of
of Immune
Immune Immunizing Dilution of
Immunizing
FV used for
Group No.
mice
status
agent
challenge Avg (g) Range (g)

1
2

3
4
5
6
7
8

10
10
8
8
8
8
10
10

Normal
Normal

Normal
Immunee
Immune
Immune
Normal
Immune

10-i
10-2

1.2 x 10O FC
1.2 x 10O FC
1.2 x 10O FC

10-3
10-i
10-2
10-a

1.2 x 10" FC

0
0

2.65
1.78
1.25
0.41
0.21
0.29
0.21
0.38

0.29-4.55
1.13-2.80
0.43-2.66
0.16-1.93
0.14-0.52
0.10-0.77
0.10-0.31
0.14-2.09

Degree of
splenomegalya

0

No. of splenic foci
1-10 10-100 Confluent

12.6x b
8.5xc

6.0xd
1.1x
0.6 x
0.8 x

1

9
10

8
8
6
5
10

2
2

1

9

1

aAverage spleen weight of infected mice per average spleen weight of uninfected mice.
1 versus 4: p < 0.001.
2 versus 5: p < 0.001.
3 versus 6: p < 0.005.
eImmunized by s.c. injection of 1.2 x
'8 versus 7: p < 0.25.

106 FC.

TABLE 3. Immunization with a single s.c. injection of FV followed 114 days later by challenge with
virus i.v. and autopsy 28 days after challenge
No. of

Group Imice
1
2
3
4
5
6

8
8
8
8
8
7

Spleen wt

Immune
Status

Dilution of
FV used for

challenge

Avg (g)

Range (g)

Immune5

10-2
10-3
10-2

0.32
0.33
1.95
1.04
0.29
0.25

0.21-0.58
0.13-0.67
0.58-3.46
0.23-1.97
0.10-0.58

Immune
Normal
Normal
Immune
Normal

10-3
0
0

0.17-0.40e

Degree of
splenomegalya
1.1 xc
1.1xd
7.8x
4.2 x

No. of splenic foci
00

110
10

5
6

3
2
1

8
7

Average spleen weight of infected mice per average spleen weight of uninfected mice.
Immunized by s.c. injection of 0.1 ml of a 10- I dilution of the FV pool.
1 versus 3: p < 0.001.
d 2 versus 4: p < 0.005.
5 versus 6: p < 0.7.
a

10-0
00

Conflu-

1

8
6

ent
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found that FV given i.v. produced typical findings of FD in normal animals, whereas animals
immunized by a single s.c. injection of FV were
resistant to i.v. infection with the virus.
Survival of immunized mice. In the following experiment three different FV or FC preparations were used to immunize groups of 50 mice
each. The animals were injected s.c. on days 0
and 21 with an inoculum of 0.1 ml which
consisted of either a 10% suspension in MEM of
spleen tissue from mice infected with FC, the
supernatant fluid obtained after centrifugation
of the 10% suspension at 4,300 x g for 30 min, or
with cells from the suspension washed eight
times with MEM. Mice of group 1 received
supernatant fluid, those in group 2 the 10%
suspension of spleen cells, and those of group 3
the washed cells. The number of cells contained
in the inoculum of 10% spleen suspension given
on day 0 was 1.3 x 107 and on day 21 was 2.5 x
107. The number of washed cells injected was
7.4 x 10 on day 0 and 2.0 x 107 on day 21. A
group of unimmunized mice was retained as
controls (group 4). Twenty-one days after the
last s.c. injection 27 mice from each group,
including the controls, were injected i.v. with
0.2 ml of a 1023 dilution of FV. Twenty
animals of each group were observed for 20
weeks in order to obtain death rates. The results
are shown in Fig. 1. The other seven mice in
each group were autopsied 11 days after infection and the number of foci in the spleens were
100]

90soj
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o
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II
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Ia
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observed. All of the unimmunized mice had
splenic foci but none was observed in the
spleens of the immunized animals.
During the observation period of 20 weeks,
80%o of the infected, unimmunized animals
succumbed, whereas only negligible numbers of
mice immunized with the spleen suspension or
supernatant fluid developed FD. Only 30% of
those immunized with the washed cell suspension died.
Persistence of resistance. Six months after
the initial immunization, the remaining mice
were challenged by i.v. injection of 0.2 ml of a
10- 23 dilution of FV. Unfortunately, the number of mice in groups 1 and 2 had been depleted
after exposure to an unrelated organism and
only four animals remained in each group. Ten
normal mice of the same age were also injected
with the same dose of virus. The animals were
held for 28 days at which time they were killed
and the spleen and body weights were determined. The data given in Table 4 show that
mice immunized by s.c. injection of spleen cell
suspension or spleen cell extracts from mice
with FV are resistant to infection with FV
administered 6 months later.
In vitro neutralization. A total of 36 mice
immunized by 3 s.c. injections of FC and 5
normal mice were used to determine the capacity of either serum or lymphoid cells to neutralize
FV. The sera and cells were collected 100 days
after the mice had received the last immunizing
injection. The results are shown in Table 5. Of
the 36 immunized donors, only 1 had marked
splenomegaly at the time cells and sera were
obtained. Among the 9 mice yielding serum
which did not neutralize virus the mean spleen
weight was 0.47 g and among the 17 mice
yielding neutralizing serum the mean spleenweight was 0.24 g. The sera of at least 75% of the
immune mice afforded protection to recipient
mice as determined by the numbers of mice
developing splenic foci, and 86% were protective
as judged by the number of animals developing

TO FDV AFTER INFECTION IN MICE

I

30

TABLE 4. Results obtained following i.v. injection of
FVinto mice immunized 6 months previously by 2 s.c.
injections of a 10%o suspension of FC, the supematant
fluid from this suspension (S), or washed spleen cells
(WFC)

-

II
II
I

t0]

I

II

In
I

ell

a

10I

I1

I VC
0

4

6

a

I

I

lo

2

14

I

1,

I

I

a

20

Group

ratio
xwt100
(%)

No. of Immunizing Avg spleen
mice

agent

wt (g)

WEEKS AFTER INCULATIONI

FIG. 1. Percent mortality among mice challenged
with FV injected i.v. after immunization by s.c.
injection of: group 1 (0), supernatant fluid from a
10% suspension of spleens of mice with FD; group 2
(0), 10% suspensions of FD spleen; group 3 (-),
8x washed cells of above suspension; group 4 (0),
unimmunized controls.

1
4
2
4
3
15
4
10
a. b a & b versus
c, dc versus d =

S
FC
WFC

0.19a
0.23b
0.20c
1.18
d = p < 0.005.
p < 0.001.

I

0.46
0.55
0.50
3.22
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splenomegaly, whereas 1.2 x 107 to 6.9 x 107
The results indicate that FV resident in the
cells were not capable of neutralizing FV. How- peritoneal cavity of normal mice for 1 h was not

ever, since the strain of mice used in this
investigation is outbred the results of tests with
lymphoid cells are not definitive.
In vivo neutralization. In this experiment an
attempt was made to determine the effect of
residence of FV in the peritoneal cavity of
normal mice and of mice immunized by s.c.
injection of FC. The test was done 130 days'after
the first of 2 s.c. injections of 106 FC given at
3-week intervals, and was performed as previously described. The animals were examined 21
days after injection and the results are shown in
Table 6.
TABLE 5. In vitro neutralization of FV by sera and
lymphoid cells taken from mice 100 days after
completion of an immunization program consisting of
three subcutaneous injections of FC given at 3-week
intervals
Immune
Group status of
donors

1
2

+

No. of recipient
Neutraliaagroups with:
tion of FV
donors with donor: Spleno- Splenic
megaly foci

No. of

dof
36

_

5

Serum
Cells

5/36

9/36

32/36

33/36

Serum
Cells

5/5
5/5

5/5
5/5

decreased in amount in comparison to FV
maintained in vitro at 37 C for the same period
of time. On the other hand, residence of virus in
the peritoneal cavity of specifically immune
mice resulted in a marked decrease in the
amount of virus present. Neither-the normal nor
the peritoneal exudate cells contained virus in
amounts comparable to those found in the
supernatant fluids. The number of recipient
animals displaying splenic foci was significantly
greater among those mice injected with 1.6 x
10. peritoneal cells from normal donors than
among mice injected with 1.9 x 106 peritoneal
cells from immune donors.
DISCUSSION
Immunization of mice against infection with
FV administered i.v. can be satisfactorily accomplished by s.c. injection of either virus or
spleen cells obtained from mice infected with
FV. A single s.c. injection of either cells or virus
suffices to immunize animals against subsequent infection. This immunity protects mice
against infection with at least 100 infectious
doses of virus (Table 1). Mice immunized by a
single s.c. injection of 1.2 x 106 spleen cells from
mice with FD are resistant to 2 logs of virus
when challenged 67 days after immunization.
Likewise, mice immunized by a single s.c.

TABLE 6. In vivo neutralization of FVafter i.p. injection of FVinto normal and FD-immune mice. Results were
obtained by i.v. injection of groups of mice with the perLoneal exudates harvested 1 h after the test mice had
been injected with FV

i.v. Injection of:
Recip- No.of
Prepamice
Donor
group

miceNoPrpsfD

1
2
3
4
5
6
7
8
9
10
11
12
13
14

10
10
10
9
10
10
10
10
10
10
10
10
10
9

PFa
PF
PF
PF
PF
PF
Virusb
Virus

Virus
PCc
PC
PC
PC

Immune mice
Immune mice
Immune mice
Normal mice
Normal mice
Normal mice

Immune mice
Immune mice
Normal mice
Normal mice

Spleen wt
Dilution of
PF or no.
Avg (g) Range (g)
of PC

Whole
1:10
1: 100

Whole
1: 10
1:100
1:10
1: 100
1:1000
1.9 x 101
1.9 x 10'
1.6 x 106
1.6 x 10'

0.37
0.31
0.22
1.87
1.02
0.31
2.38
0.95
0.36
0.36
0.23
0.53
0.27
0.18

No. of splenic foci
Degree of
spleno-Cofu
1-10 10-100 Centflu
0
megaly

0.17-0.92 2.1xd, e
0.14-0.50 1.7 x
0.17-0.28 1.2x
0.33-3.34 10.5 x
0.18-2.58 5.7x
0.20-0.58 1.7 x
0.47-3.12 13.2x
0.24-2.52 5.3x
0.19-0.69 2.Ox
0.20-0.96 2.Ox
0.14-0.32
0.24-1.96
0.17-0.67
0.11-0.24

1.3 x

2.9x
1.5 x

2
5
7
2

3
4
7
2
5

5
5
3

2

1

1
1
5

3
2
2
3

1
3
2

8
9
1
10
6
2
2

1

1
2

6
2

2

9

a Supernatant fluid of peritoneal exudate.
FV maintained at 37 C for 1 h.
c Cells of peritoneal exudate.
d Average weight of spleen of infected mice per average weight of spleen of uninfected mice.
e Mice autopsied 21 days after injection.
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injection of 0.1 ml of a 1:10 dilution of FV are
immune when challenged 114 days after immunization.
Not only are mice resistant to the development of splenic foci and splenomegaly, but
survival is extended for at least 20 weeks after
i.v. injection of FV. Animals immunized with a
suspension of spleen cells from mice with Friend
disease, with the supernatant fluid from this
suspension, or FC washed eight times survive
for 20 weeks after i.v. injection of FV. Animals
immunized with the above preparations and
challenged 6 months after immunization are
resistant to challenge. It is of interest to note
that after challenge with FV most of the deaths
among animals immunized with FC occurred
before deaths occurred in the control mice.
Studies of the mortality rate due to s.c.
injection of FV or FC have not been specifically
carried out but some idea of the effect of live
material administered by this route can be
obtained from other observations. Thus, among
the 92 immunized mice included in the tables,
only 3 had enlarged spleens at the time of
autopsy. At least 84% of mice immunized with
washed spleen cells survived for 42 days after
immunization and 14 of 23 animals survived for
at least 6 months after receiving an s.c. injection of cells. In one experiment the mortality
rate was about 35% and in others the mortality
rates were approximately 10% 6 months after
immunization. These figures are to be compared with those reported by Old et al. (12) and
Rich et al. (15).
Lilly (10) has reported upon the resistance of
certain strains of mice to the F-S and F-B
strains of FV. F-S is a strain of FV adapted to
Swiss mice and F-B is a strain adapted to
BALB/c mice. Infection of BALB/c mice with
F-S virus does not result in FD among them except when high concentrations of F-S are administered, but induces resistance to a subsequent inoculation of F-B virus. Rawson and
Parr (17) and Bendinelli and Nordini (4) have
shown that Rawson-Parr virus (RPV) produces
resistance to subsequent infections with FV.
The former authors did not find neutralizing FV
antibodies in the plasma of RPV-infected mice,
but the latter workers attribute resistance of
RPV-infected mice to infections with FV to neutralizing antibodies against the latter agent.
Other studies have shown that strains of Rauscher and Friend virus maintained on tissue
cultures will also produce resistance in mice to
infection with standard FV (3, 8, 18, 20). The
studies of Old et al. (12) yielded results similar
to the present ones in terms of the infectivity
of FC or FV injected s.c. into mice. Large numbers of animals infected by this route did not
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develop leukemia, but developed antibodies
cytotoxic for FC.
Resistance which develops after s.c. injection
of FC or FV appears to be related to humoral
immunity. It is generally agreed that FD is
initiated by infection of the reticulum cells in
the spleen and that involvement of the lymph
nodes is absent or minimal (14). Administration
of FV by the s.c. route may result in a minimal
spread of virus through the circulation and in a
prompt response in the regional lymph nodes.
The vast majority of mice inoculated by this
method are capable of preventing FV from
spreading to the spleen from the site of s.c.
injection. The number of cells or amount of
virus utilized to induce resistance by s.c. injection in these experiments contains at least 3 logs
of infectious material as shown by the development of FD in mice after i.v. injection. Neutralization tests show that serum from immunized
mice is capable of neutralizing virus in vitro and
studies of the effect of residence of FV in the
peritoneal cavity of immune mice indicate that
FV is neutralized in vivo. No evidence of
delayed hypersensitivity has been found in
immune mice using either plasma virus, infected spleen cells, or peritoneal exudate cells as
antigen in footpad tests (C. L. Larson, unpublished data). Transfer of spleen cells from immune mice to normal mice does not result in
transfer of resistance. These results do not differ
significantly from those obtained by Fink et al.
(6) and Friend (7) in their studies of resistance
caused by immunization of mice with Formalinkilled Rauscher virus or FV. A recent review by
Allison (1) emphasizes that infections due to
different viruses may be controlled by either
humoral immunity or cell-mediated immunity.
Infections due to FV appear to be controlled by
the former mechanism.
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